[Biological immunomodulators in the treatment of cancer].
Bello
C
C
Richard
C
C
Hermosa
V
V
Iriondo
A
A
Muruzábal
M J
MJ
Pérez Encinas
M
M
Zubizarreta
A
A
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000912:Antibodies, Neoplasm / Q000627:therapeutic use; D006801:Humans; D007111:Immunity, Cellular; D007372:Interferons / Q000494:pharmacology / Q000627:therapeutic use; D007376:Interleukin-2 / Q000494:pharmacology / Q000627:therapeutic use; D007694:Killer Cells, Natural / Q000276:immunology / Q000637:transplantation; D009369:Neoplasms / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000145:classification / Q000276:immunology
D000276:Adjuvants, Immunologic; D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D007376:Interleukin-2; D011994:Recombinant Proteins; D007372:Interferons
Inmunomoduladores biológicos en el tratamiento del cáncer.